Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial.
Nous-209 新抗原疫苗用于预防林奇综合征携带者的癌症:一项 1b/2 期试验。
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04182-9
D'Alise Anna Morena, Willis Jason, Duzagac Fahriye, Hall Michael J, Cruz-Correa Marcia, Idos Gregory E, Thirumurthi Selvi, Ballester Veroushka, Leoni Guido, Garzia Irene, Antonucci Laura, De Marco Lorenzo, Micarelli Elisa, Deng Nan, Seclì Laura, Gogov Sven, Dong Wenli, Jack Lee J, Bowen Charles M, Vornik Lana A, Garcia-Gonzalez Araceli, Reyes-Uribe Laura, Richmond Ellen, Umar Asad, Brown Powel H, Sinha Krishna M, Rodriguez Luz Maria, Scarselli Elisa, Vilar Eduardo